Degradable hydrogels derived from PEG-diacrylamide for hepatic tissue engineering
- PMID: 25851120
- PMCID: PMC4890565
- DOI: 10.1002/jbm.a.35478
Degradable hydrogels derived from PEG-diacrylamide for hepatic tissue engineering
Abstract
Engineered tissue constructs have the potential to augment or replace whole organ transplantation for the treatment of liver failure. Poly(ethylene glycol) (PEG)-based systems are particularly promising for the construction of engineered liver tissue due to their biocompatibility and amenability to modular addition of bioactive factors. To date, primary hepatocytes have been successfully encapsulated in non-degradable hydrogels based on PEG-diacrylate (PEGDA). In this study, we describe a hydrogel system based on PEG-diacrylamide (PEGDAAm) containing matrix-metalloproteinase sensitive (MMP-sensitive) peptide in the hydrogel backbone that is suitable for hepatocyte culture both in vitro and after implantation. By replacing hydrolytically unstable esters in PEGDA with amides in PEGDAAm, resultant hydrogels resisted non-specific hydrolysis, while still allowing for MMP-mediated hydrogel degradation. Optimization of polymerization conditions, hepatocellular density, and multicellular tissue composition modulated both the magnitude and longevity of hepatic function in vitro. Importantly, hepatic PEGDAAm-based tissues survived and functioned for over 3 weeks after implantation ectopically in the intraperitoneal (IP) space of nude mice. Together, these studies suggest that MMP-sensitive PEGDAAm-based hydrogels may be a useful material system for applications in tissue engineering and regenerative medicine. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 3331-3338, 2015.
Keywords: PEGDAAm; liver; matrix metalloproteinase; polyethylene glycol diacrylamide; tissue engineering.
© 2015 Wiley Periodicals, Inc.
Figures






References
-
- Lee SW, Wang X, Chowdhury NR, Roy‐Chowdhury J. Hepatocyte transplantation: State of the art and strategies for overcoming existing hurdles. Ann Hepatol 2004;3:48–53. - PubMed
-
- Matas AJ, Sutherland DE, Steffes MW, Mauer SM, Sowe A, Simmons RL, Najarian JS. Hepatocellular transplantation for metabolic deficiencies: Decrease of plasms bilirubin in gunn rats. Science 1976;192:892–894. - PubMed
-
- Bernardi M, Tacconi C, Somaroli M, Gasbarrini G, Mazziotti A. Hyperammonemic, ammonia‐independent coma in experimental acute liver failure induced in the pig. Gastroenterology 1981;81:191–192. - PubMed
-
- Demetriou AA, Reisner A, Sanchez J, Levenson SM, Moscioni AD, Chowdhury JR. Transplantation of microcarrier‐attached hepatocytes into 90% partially hepatectomized rats. Hepatology 1988;8:1006–1009. - PubMed
-
- Kobayashi N, Fujiwara T, Westerman KA, Inoue Y, Sakaguchi M, Noguchi H, Miyazaki M, Cai J, Tanaka N, Fox IJ, Leboulch P. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000;287:1258–1262. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources